Items where Author is "Fordham, Sarah E."

Tirtakusuma, Ricky, Szoltysek, Katarzyna, Milne, Paul, Grinev, Vasily, Ptasinska, Anetta, Chin, Paulynn Suyin, Meyer, Claus, Nakjang, Sirintra, Hehir-Kwa, Jayne Y., Williamson, Daniel, Cauchy, Pierre, Keane, Peter, Assi, Salam a, Ashtiani, Minoo, Kellaway, Sophie G., Imperato, Maria R., Vogiatzi, Fotini, Schweighart-James, Elizabeth K., Lin, Shan, Wunderlich, Mark, Stutterheim, Janine, Komkov, Alexander, Zerkalenkova, Elena, Evans, Paul, McNeill, Hesta Varey, Elder, Alex, Martínez-Soria, Natalia, Fordham, Sarah E., Shi, Yuzhe, Russell, Lisa J., Pal, Deepali, Smith, Alexandra G., Kingsbury, Zoya, Becq, Jennifer, Eckert, Cornelia, Haas, Oskar A,, Carey, Peter, Bailey, Simon, Skinner, Roderick, Miakova, Natalia, Collin, Matthew, Bigley, Venetia, Haniffa, Muzlifah, Marschalek, Rolf, Harrison, Christine J., Cargo, Catherine A., Schewe, Denis Martin, Olshanskaya, Yulia, Thirman, Michael J., Cockerill, Peter N., Mulloy, James C., Blair, Helen J., Vormoor, H. Josef, Allan, James M., Bonifer, Constanze, Heidenreich, Olaf and Bomken, Simon (2022) Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. Blood, 140 (17). pp. 1875-1890. ISSN 0006-4971

Fordham, Sarah E., Blair, Helen J., Elstob, Claire J., Plummer, Ruth, Drew, Yvette, Curtin, Nicola J., Heidenreich, Olaf, Pal, Deepali, Jamieson, David, Park, Catherine, Pollard, John, Fields, Scott, Milne, Paul, Jackson, Graham H., Marr, Helen J., Menne, Tobias, Jones, Gail L. and Allan, James M. (2018) Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase. Blood Advances, 2 (10). pp. 1157-1169. ISSN 2473-9529

Moad, Mohammad, Pal, Deepali, Hepburn, Anastasia C., Williamson, Stuart C., Wilson, Laura, Lako, Majlinda, Armstrong, Lyle, Hayward, Simon W., Franco, Omar E., Cates, Justin M., Fordham, Sarah E., Przyborski, Stefan, Carr-Wilkinson, Jane, Robson, Craig N. and Heer, Rakesh (2013) A Novel Model of Urinary Tract Differentiation, Tissue Regeneration, and Disease: Reprogramming Human Prostate and Bladder Cells into Induced Pluripotent Stem Cells. European Urology, 64 (5). pp. 753-761. ISSN 0302-2838